Recite me link

In the past 12 months, how many patients were treated with:
Avelumab + Axitinib
Axinitib
Bevacizumab
Cabozantinib
Doxorubicin
Everolimus
Lapatinib
Lenvantinib
Lenvantinib + Everolimus
Nivolumab
Nivolumab + Ipilimumab
Pazopanib
Pembrolizumab + Axitinib
Regorafenib
Sorafenib
Sunitinib
Temsirolimus
Tivozanib
Vandetanib

Download response Drugs usage. 061119